Preventing Major Adverse Cardiovascular Events by SGLT-2 Inhibition in Patients With Type 2 Diabetes: The Role of Kidney
Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-020-01010-x
Full Text
Open PDFAbstract
Available in full text
Date
March 19, 2020
Authors
Publisher
Springer Science and Business Media LLC